L-asparaginase in the treatment of neoplastic diseases of the dog, cat and cow.
D000818:Animals; D000917:Antibody Formation; D001215:Asparaginase / Q000097:blood / Q000627:therapeutic use* / Q000633:toxicity; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy*; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004342:Drug Hypersensitivity / Q000209:etiology; D004926:Escherichia coli / Q000201:enzymology*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000662:veterinary; D012515:Mast-Cell Sarcoma / Q000188:drug therapy / Q000662:veterinary; D008545:Melanoma / Q000188:drug therapy / Q000662:veterinary; D009369:Neoplasms / Q000188:drug therapy / Q000662:veterinary; D012377:Rodentia / Q000201:enzymology
D001215:Asparaginase